• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

SLT is a cost-effective, first-line glaucoma approach


Selective laser trabeculoplasty (SLT) could be an affordable option for glaucoma management, according to Nathan Radcliffe, MD. 

Nathan Radcliffe, MD, shares why selective laser trabeculoplasty (SLT) is a cost-effective, first-line approach for glaucoma patients at the annual 2019 ASCRS meeting in San Diego. You can read more about the research on this topic here.

RELATED: Moderate-monovision outcomes see improvement with small aperture IOLs

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
Elizabeth Yeu, MD, highlights from a corneal case report for a patient undergoing the triple procedure
© 2024 MJH Life Sciences

All rights reserved.